Progesteron’s agonist Dydrogesteron in the treatment of the miscarriage

M. A. Repina; Репина М. А.; N. E. Lebedeva; Лебедева Н. Е.; L. P. Zdanuk; Жданюк Л. П.; A. V. Ivanova; Иванова А. В.

doi:10.17816/JOWD88936

Progesteron’s agonist Dydrogesteron in the treatment of the miscarriage

Authors: Repina M.A.¹^,2, Lebedeva N.E.¹^,2, Zdanuk L.P.¹^,2, Ivanova A.V.¹^,2
Affiliations:
1. Medical Academy of Postgraduate Education
2. City Hospital No.2
Issue: Vol 49, No 1 (2000)
Pages: 36-38
Section: Original study articles
URL: https://journals.rcsi.science/jowd/article/view/88936
DOI: https://doi.org/10.17816/JOWD88936
ID: 88936

Cite item

Full Text

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

The study was earned out to investigate effect of Progesterone 's agonist Dydrogesterone in the treatment оf the miscarriage. Thus, it was seen that Dydrogesterone 's treatment (10 mg/daily per os) zvas more effective than Progesterone for prophylactic miscarriage.